- Q1 2024 DiaSorin SpA Earnings Call TranscriptMay 10, 2024$107.4Earnings
- Q3 2023 DiaSorin SpA Earnings Call TranscriptNov 03, 2023$87.45Earnings
- Half Year 2023 DiaSorin SpA Earnings Call TranscriptJul 27, 2023$96Earnings
- Q1 2023 DiaSorin SpA Earnings Call TranscriptMay 09, 2023$119.74Earnings
- Full Year 2022 DiaSorin SpA Earnings Call TranscriptMar 27, 2023$111.33Earnings
- Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call TranscriptFeb 13, 2023
- Q3 2022 DiaSorin SpA Earnings Call TranscriptOct 27, 2022$107Earnings
- Q2 2022 DiaSorin SpA Earnings Call TranscriptAug 03, 2022$144.11Earnings
- Q1 2022 DiaSorin SpA Earnings Call TranscriptMay 06, 2022$129Earnings
- Q4 2021 DiaSorin SpA Earnings Call TranscriptMar 16, 2022$130Earnings
- DiaSorin SpA Investor Day TranscriptDec 17, 2021
- Q3 2021 DiaSorin SpA Earnings Call TranscriptNov 11, 2021$220.95Earnings
- Q2 2021 DiaSorin SpA Earnings Call TranscriptJul 30, 2021$203.44 (+1.72%)Earnings
- Q1 2021 DiaSorin SpA Earnings Call TranscriptMay 14, 2021$173.25Earnings
- DiaSorin SpA to Acquire Luminex Corp Call TranscriptApr 12, 2021
- Q4 2020 DiaSorin SpA Earnings Call TranscriptMar 11, 2021$219Earnings
- Q3 2020 DiaSorin SpA Earnings Call TranscriptNov 11, 2020$183Earnings
- Q2 2020 DiaSorin SpA Earnings Call TranscriptJul 30, 2020$202.18Earnings
- Q1 2020 DiaSorin SpA Earnings Call TranscriptMay 13, 2020$169.66Earnings
- Q4 2019 DiaSorin SpA Earnings Call TranscriptMar 11, 2020$118.43 (-3.34%)Earnings
- Q3 2019 DiaSorin SpA Earnings Call TranscriptNov 06, 2019$114.75Earnings
- Q2 2019 DiaSorin SpA Earnings Call TranscriptJul 31, 2019$114.75Earnings
- DiaSorin SpA Investor Day TranscriptJun 11, 2019
- Q1 2019 DiaSorin SpA Earnings Call TranscriptMay 09, 2019$100.1Earnings
- Q4 2018 DiaSorin SpA Earnings Call TranscriptMar 14, 2019$95.67Earnings
Q2 2019 DiaSorin SpA Earnings Call Transcript
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin First Half 2019 Results Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Yes. Thank you, operator. Ladies and gentlemen, welcome to the quarter 2 conference call. As usual, I'm going to give you some general comments about what happened in quarter 2. And then our CFO, Mr. Pedron, will drive you through the numbers. Again, as usual, I'm going to comment on our results in constant exchange rate, since as you know, there is a variation, especially on the dollar side, which has been clearly impacting, in this case, on the positive side, the financial of the company. So everything I will comment on is going to be a constant exchange rate.
So let's start from the top line. It was a very good quarter. The growth at the group level was 6%. And what is very interesting to look at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)